Skip to content

13F-HR filed by AIGH Capital Management LLC

AIGH Capital Management LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-12, with 52 holding rows worth $475,511,000.

Accession
0001214659-21-011426
Filed
2021-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A combination report, 101 entries on the cover page, a total value of $475,511,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $475,511,000 with VALUE read as thousands by filing date, 13F file number 028-20823. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS500,000$109,375,000thousands by filing dateput
SILICON MOTION TECHNOLOGY CORP SPONSORED ADR82706C108ADR1,468,735$29,117,000thousands by filing date
EMCORE CORP290846203COM3,370,153$25,209,000thousands by filing date
PDF SOLUTIONS INC693282105COMMON STOCK1,005,000$23,156,000thousands by filing date
PHOTRONICS INC719405102COM1,370,734$18,683,000thousands by filing date
AVIAT NETWORKS INC05366Y201COMMON STOCK554,682$18,227,000thousands by filing date
BRIDGELINE DIGITAL INC10807Q700COM1,259,644$17,214,000thousands by filing date
GALERA THERAPEUTICS EQUICLASS EQUITY36338D108COMMON STOCK2,036,495$16,496,000thousands by filing date
ADTRAN INC00738A106COMMON STOCK812,656$15,246,000thousands by filing date
O2MICRO INTERNATIONAL LTD67107W100SPONS ADR2,458,402$14,849,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM2,585,743$12,696,000thousands by filing date
AVEO PHARMACEUTICALS INC053588307COM1,986,176$12,275,000thousands by filing date
THERATECHNOLOGIES INC COM88338H100COM3,023,036$11,962,000thousands by filing date
DZS INC268211109COMMON STOCK969,015$11,880,000thousands by filing date
PDS BIOTECHNOLOGY CORP70465T107COM773,560$11,527,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM1,664,540$8,805,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM1,234,121$8,207,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity1,609,398$7,821,000thousands by filing date
EDAP TMS S A268311107SPONSORED ADR1,208,250$7,709,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK864,427$6,059,000thousands by filing date
AVAYA HLDGS CORP05351X101COM300,000$5,937,000thousands by filing datecall
AMERICAN SUPERCONDUCTOR CORP030111207SHS NEW395,487$5,766,000thousands by filing date
FRANKLIN WIRELESS CORP355184102COM780,000$5,663,000thousands by filing date
CYBEROPTICS CORP COM232517102Stock116,566$4,147,000thousands by filing date
MYOMO INC62857J201COM NEW348,125$4,139,000thousands by filing date
RF INDUSTRIES LTD749552105COMMON STOCK495,037$4,035,000thousands by filing date
WIRELESS TELECOM GROUP INC976524108COM1,867,639$3,866,000thousands by filing date
TRANSCODE THERAPEUTICS INC89357L105CMN1,270,500$3,798,000thousands by filing date
BK Technologies Corp.05587G104COM1,340,000$3,786,000thousands by filing date
Allena Pharmaceuticals, Inc.018119107COM4,000,000$3,608,000thousands by filing date
BRAINSWAY LTD10501L106CMN440,301$3,549,000thousands by filing date
HTG MOLECULAR DIAGNOSTICS IN40434H203COM NEW612,000$3,494,000thousands by filing date
PROCESSA PHARMACEUTICALS INC COM NEW74275C205Stock387,097$3,317,000thousands by filing date
AMTECH SYSTEMS INC032332504COMMON STOCK273,100$3,121,000thousands by filing date
DATA I O CORP237690102COM418,310$2,731,000thousands by filing date
MEDICENNA THERAPEUTICS F58490H107FOREIGN CANADIAN915,000$2,544,000thousands by filing date
ACACIA RESEARCH CORP003881307COMMON STOCK362,906$2,464,000thousands by filing date
CYCLO THERAPEUTICS INC23254X201Common Stock350,000$2,363,000thousands by filing datecall
EVOKE PHARMA INC30049G104COM1,701,185$2,211,000thousands by filing date
IDEAL PWR INC451622203COM NEW144,347$2,197,000thousands by filing date
ALIMERA SCIENCES INC016259202COM501,025$2,115,000thousands by filing date
ANNOVIS BIO INC03615A108COM66,469$2,110,000thousands by filing date
NLS PHARMACEUTICS LTDH57830111*W EXP 02/02/202827,921$2,069,000thousands by filing datecall
YIELD10 BIOSCIENCE INC98585K862COM342,000$2,049,000thousands by filing date
ONDAS HLDGS INC68236H204COM NEW207,070$1,898,000thousands by filing date
SCYNEXIS INC811292200COM NEW343,126$1,819,000thousands by filing date
NUWELLIS INC67113Y108COM760,000$1,671,000thousands by filing date
DERMATA THERAPEUTICS INC249845108COM175,000$786,000thousands by filing date
DERMATA THERAPEUTICS INC249845108COM175,000$786,000thousands by filing datecall
ARIDIS PHARMACEUTICALS INC040334104COMMON STOCK150,591$554,000thousands by filing date
PETVIVO HLDGS INC EQUITYCLASS EQUITY716817408COMMON STOCK100,000$270,000thousands by filing datecall
PETVIVO HLDGS INC EQUITYCLASS EQUITY716817408COMMON STOCK50,000$135,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-21-011426this filing2021-11-12acceptance time not in the bulk data set